Status:
COMPLETED
Chronic Posterior Laryngitis With Suspected Laryngopharyngeal Reflux
Lead Sponsor:
AstraZeneca
Conditions:
Chronic Posterior Laryngitis (CPL)
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study looks at how effective acid suppression therapy is on symptoms associated with chronic posterior laryngitis (CPL) in patients with documented pharyngeal acid reflux.
Eligibility Criteria
Inclusion
- One or more of the following symptoms present for at least 3 consecutive months: throat clearing, cough, globus, sore throat, or hoarseness.
- Patients must complete a run-in diary card, and this will be looked at to ensure met the inclusion criteria.
- Must have a total score of 5 or more on the Chronic Posterior Laryngitis Index (CPLI) grading system.
Exclusion
- A number of diseases / conditions would preclude a patient from taking part in the study, as listed in the protocol.
- If the patient is on certain medications this will also preclude them from taking part.
Key Trial Info
Start Date :
February 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2003
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00628667
Start Date
February 1 2002
End Date
March 1 2003
Last Update
January 25 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.